Pay in 4 interest-free payments of $5.46 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Ipragliflozin additively ameliorates non-alcoholic fatty liver disease in patients with type 2 diabetes controlled with metformin and pioglitazone: a 24-Week randomized controlled trial
(1) This may upregulate growth hormone (GH) synthesis, which is a hormone with catabolic potential towards fat cells, and also may possess anabolic potential via a mediator called insulin-like growth factor 1 (IGF-1) The research suggests that it may produce rapid, concentration-dependent, pulsatile GH elevations, yielding GH pulses roughly 20- to 30-fold above basal values and potentially close to other GHSs such as GHRP-6 and GHRP-2
Enterocyte DPP-4 is dispensable for sitagliptin-mediated reduction of postprandial lipid excursion
A combination of cytokines EGF and CNTF protects the functional beta cell mass in mice with short-term hyperglycaemia
Zaias N, Ackerman AB
Enterococci as probiotics and their implications in food safety
US$ 28.63
US$ 25.93
US$ 29.05
US$ 22.71
US$ 29.05
